Lower prices for 15 drugs, including Ozempic and Wegovy, are expected to be announced by the end of the month. The price negotiation program was created under Biden.

President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy.

The White Houes may have struck a deal with Eli Lilly and Novo Nordisk last week to lower the costs of their weight loss drugs for patients, but knockoff versions of Zepbound and Wegovy still permeate the obesity market.

Middle-class Indians trying to lose weight are embracing drugs such as Mounjaro, which is also used to treat diabetes in a country that has been called the world’s diabetes capital.

The White House is in discussions with the makers of weight loss drugs Wegovy and Zepbound to drastically lower prices, NBC News has learned. The prices could drop from an average price of $1,300 a month to $150 a month,

The Danish pharmaceutical giant Novo Nordisk has struck an agreement with the Centers for Medicare & Medicaid Services (CMS) to set a negotiated price for